|
ZNF642 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.621570E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.785100E-04 |
| Normal-vs-Stage2 |
8.712400E-02 |
| Normal-vs-Stage3 |
8.569200E-01 |
| Normal-vs-Stage4 |
9.379600E-01 |
| Stage1-vs-Stage2 |
8.965200E-01 |
| Stage1-vs-Stage3 |
1.301760E-02 |
| Stage1-vs-Stage4 |
5.963000E-01 |
| Stage2-vs-Stage3 |
1.090980E-01 |
| Stage2-vs-Stage4 |
5.871800E-01 |
| Stage3-vs-Stage4 |
8.972200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.696000E-03 |
| Normal-vs-AfricanAmerican |
1.159960E-02 |
| Normal-vs-Asian |
5.392800E-01 |
| Caucasian-vs-AfricanAmerican |
7.513800E-01 |
| Caucasian-vs-Asian |
8.459200E-01 |
| AfricanAmerican-vs-Asian |
7.674600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.896200E-03 |
| Normal-vs-Female |
2.435100E-03 |
| Male-vs-Female |
2.085200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.004000E-02 |
| Normal-vs-Extreme_Weight |
1.306410E-02 |
| Normal-vs-Obese |
7.534500E-02 |
| Normal-vs-Extreme_Obese |
6.121900E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.079800E-01 |
| Normal_Weight-vs-Obese |
5.880600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.917800E-01 |
| Extreme_Weight-vs-Obese |
7.562200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.643200E-01 |
| Obese-vs-Extreme_Obese |
6.976200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.514800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.212100E-04 |
| Normal-vs-Age(61-80Yrs) |
8.640600E-03 |
| Normal-vs-Age(81-100Yrs) |
7.930600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.448200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.313770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.339000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.059400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.689990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.413600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.80989999999981E-05 |
| Normal-VS-Type2 PRCC |
1.812450E-01 |
| Normal-VS-KIRP CIMP |
1.15379999998666E-08 |
| Normal-VS-Unclassified PRCC |
1.070060E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.237600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.01329999946387E-08 |
| Type1 PRCC-VS-Unclassified PRCC |
8.954200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.86280002534289E-09 |
| Type2 PRCC-VS-Unclassified PRCC |
2.648600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.96699997903715E-10 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.174600E-01 |
| Normal-vs-N1 |
5.382000E-01 |
| Normal-vs-N2 |
6.804000E-01 |
| N0-vs-N1 |
7.885800E-01 |
| N0-vs-N2 |
2.695800E-01 |
| N1-vs-N2 |
6.088200E-01 |
|
|
